Importantly, it has also been shown that the disruptions of U2AF1 expression that occur in patients with lung adenocarcinoma also cause changes in SMN2 splicing (Kim et al, 2018), emphasizing that variations of U2AF1 and SMN2 splicing also occur in humans in vivo. This evidence concerns the gene U2AF1 and lung adenocarcinoma.